Copy Link Print Information

Rovalpituzumab

(Synonyms: SC-0001)
1 Cited Publications
Avis client

Based on 1 publication(s) in Google Scholar

Rovalpituzumab is a humanized monoclonal antibody against delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine. Rovalpituzumab has activity against small cell lung cancer (SCLC).

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • Pureté: 99.84%
  • CAS No.: 1613313-01-1
  • Masse moléculaire:145.02 kDa
  • Stockage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Rovalpituzumab
  • Experimental Validation Results for Rovalpituzumab
  • Experimental Validation Results for Rovalpituzumab
  • Rovalpituzumab Chemical Structure
    Rovalpituzumab Chemical Structure
CAS No.: 1613313-01-1
Size
Prix
Stock
Quantité
Amount: USD 0.00
Please select quantity
or
or

* Veuillez sélectionner la quantité avant d'ajouter des articles.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Rovalpituzumab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Trouvez votre distributeur local Your local distributor: Hycultec GmbHHycultec
  • Activité biologique
  • Chemical Information
  • Pureté et documentation
  • Références
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Rovalpituzumab

More
Keywords
MOQ
Minimum order quantity
100 mg

Obtenir un devis En stock

Other size
Obtenir un devis
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Enregistrer
Sign in to MedChemExpress
Enregistrer un nouveau compte

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG1 kappa

  • 1/16

    Immobilized Delta-like protein 3/DLL3 Protein, Human (Biotinylated, HEK293, His, HY-P78115) can bind Rovalpituzumab. The EC50 for this effect is 3.245 ng/mL.

  • 1/16

    Flow cytometric analysis of 1X106 U118MG cells with Rovalpituzumab (HY-P99043, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. AF 488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

  • Rovalpituzumab Chemical Structure
    1/16
  • Rovalpituzumab
  • Immobilized Delta-like protein 3/DLL3 Protein, Human (Biotinylated, HEK293, His, HY-P78115) can bind Rovalpituzumab. The EC50 for this effect is 3.245 ng/mL.
  • Flow cytometric analysis of 1X106 U118MG cells with Rovalpituzumab (HY-P99043, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. AF 488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).